Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Facilities

Manufacture Process Control

The Phoenix of Process Innovation

| James Strachan, Stephanie Sutton

Meet CPI: the UK not-for-profit dedicated to de-risking innovation.

Manufacture Small Molecules

Wet, Wet, Wet

| Stephanie Sutton

Continuous wet granulation will be the star of a new UK facility, which stems from a collaboration between CPI, GSK and AstraZeneca.

Business & Regulation Business Practice

Business in Brief

| Maryam Mahdi

Scouting for new leadership, prices hikes and successful acquisitions. What’s new for pharma in business?

Manufacture Bioprocessing - Upstream & Downstream

Trials of a Medicine Maker

Fail to Prepare? Prepare to Fail…

Manufacture Bioprocessing - Upstream & Downstream

Trials of a Medicine Maker

Gene finds that the pressures of viral vector manufacturing are almost too much.

Manufacture Technology and Equipment

Your Digital Twin

| Stephanie Sutton

By simulating processes in a digital twin of a facility, changes can be safely tested before application in the real world.

Manufacture Bioprocessing - Upstream & Downstream

Turning up the Heat for Virus Removal (ms)

| Sponsored by MilliporeSigma

Viral contamination can have devastating effects. But innovations upstream can help prevent that.

Manufacture Standards & Regulation

A Continuous Cycle of Success

| David Thompson

Helping to meet demands and reduce shortages... Is continuous manufacturing the way forward for pharma?

Manufacture Contract Manufacturing Services

Perks and Pitfalls of Antibody Drug Conjugates

| Stephanie Sutton

ADCs have suffered a few setbacks over the years, but interest in their therapeutic potential – particularly against cancer – remains high.

Manufacture Advanced Medicine

NextGen Now: Delivering Tomorrow's Facilities Today

| Ryan McDonough

If cell and gene therapy products are to successfully reach patients, then the industry will need more facilities capable of manufacturing them.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register